Hip Replacement Market Size, Share, Growth, and Industry Analysis, By Type (Total Hip Replacement Implant,Partial Hip Replacement Implant,Hip Resurfacing Implant,Revision Hip Replacement Implant), By Application (Hospitals,Orthopedics Clinics,Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Hip Replacement Market Overview

The global Hip Replacement Market size is projected to grow from USD 2929.14 million in 2026 to USD 3035.77 million in 2027, reaching USD 13195.52 million by 2035, expanding at a CAGR of 3.64% during the forecast period.

The Hip Replacement market witnessed over 1.6 million hip implant procedures globally in 2024, with 58% being total hip replacements, 21% partial replacements, and 12% revision surgeries. Around 67% of procedures used cementless implants, and 43% incorporated advanced ceramic bearings. North America and Europe accounted for 61% of global procedures, while Asia-Pacific represented 27% with rapid growth in India and China. Around 19% of surgeries in 2024 were outpatient-based, supported by technological advancements in minimally invasive approaches. The Hip Replacement market Report highlights rising demand for durable implants to support the aging global population.

The USA performed around 450,000 hip replacement surgeries in 2024, representing 28% of the global total. Around 62% of U.S. hip replacements were cementless implants, while 31% used cemented formats. Total hip replacements accounted for 63% of procedures, partial implants 20%, and revisions 12%. Outpatient hip replacements grew to 22% of all cases, reflecting adoption of minimally invasive surgical techniques. Around 46% of U.S. hospitals adopted robotic-assisted hip replacement technologies. Around 38% of procedures involved patients over 65 years, while 17% targeted younger patients with hip resurfacing. The Hip Replacement market Analysis positions the USA as the largest regional contributor.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 67% growth driven by rising demand from aging population and higher prevalence of osteoarthritis.
• Major Market Restraint: 42% limitation due to implant recalls and stringent regulatory approval processes.
• Emerging Trends: 54% adoption of minimally invasive and robotic-assisted hip replacement procedures.
• Regional Leadership: 39% of global market share held by North America in 2024.
• Competitive Landscape: Top 5 companies controlled 47% of global hip replacement implant share.
• Market Segmentation: Total hip replacements accounted for 46% of global procedures in 2024.
• Recent Development: 31% increase in adoption of ceramic and titanium-based implants between 2023 and 2024.

Hip Replacement market Latest Trends

The Hip Replacement market is increasingly adopting robotic-assisted and minimally invasive surgical procedures, with 54% of new installations in 2024 supporting robotic navigation. Around 43% of hospitals globally integrated advanced imaging technologies for precision-based hip replacement planning. Outpatient hip replacement procedures accounted for 19% of global cases in 2024, up from 14% in 2022. Around 67% of new implants were cementless, while 33% used cemented designs. Ceramic-on-ceramic bearings accounted for 22% of implants, while 31% used ceramic-on-polyethylene, and 18% used metal-on-polyethylene. Around 36% of patients globally were under the age of 65, reflecting rising demand from younger populations. The Hip Replacement market Growth is reinforced by innovations in biomaterials, with 29% of 2024 product launches including advanced titanium alloys. Around 41% of orthopedic surgeons globally reported better recovery outcomes with modern implants, reducing revision rates by 17%. The Hip Replacement market Insights confirm strong alignment with patient outcomes and technological advancement.

Hip Replacement market Dynamics

DRIVER

"Increasing prevalence of osteoarthritis and aging population."

In 2024, over 650 million people worldwide suffered from osteoarthritis, with 38% requiring hip replacement interventions. Around 46% of global procedures were conducted on patients above 65 years. Around 29% of procedures were tied to traumatic hip fractures. Around 19% of patients under 50 opted for hip resurfacing as a joint-preserving option. Around 72% of hospitals offering orthopedic care integrated hip replacement surgeries as standard procedures. Around 31% of new procedures in 2024 were performed using robotic-assisted techniques. The Hip Replacement market Outlook highlights aging demographics and rising osteoarthritis prevalence as the leading growth driver.

RESTRAINT

"Implant recalls and regulatory delays."

Around 42% of regulatory interventions in 2024 were linked to implant recalls and safety audits. Around 11% of hip replacement implants globally were recalled due to wear-related issues. Around 26% of hospitals reported delays in implant approval processes, extending average adoption timelines by 12–14 months. Around 19% of orthopedic clinics reported cost burdens due to regulatory compliance upgrades. Around 31% of patients expressed concerns about implant longevity, with 13% of patients avoiding surgery due to perceived risks. The Hip Replacement market Report emphasizes regulatory challenges as a significant barrier to expansion.

OPPORTUNITY

"Expansion in outpatient and minimally invasive procedures."

Outpatient hip replacement procedures increased to 19% of total surgeries in 2024, representing 305,000 patients globally. Around 27% of hospitals globally established specialized outpatient orthopedic units. Around 33% of orthopedic surgeons adopted minimally invasive approaches, reducing hospital stays by 29%. Around 38% of patients under 55 years preferred minimally invasive options due to faster recovery times. Around 17% of insurance providers globally expanded coverage to include outpatient hip replacement services. Around 22% of global investments in 2024 targeted outpatient surgical centers. The Hip Replacement market Opportunities highlight outpatient expansion as a key revenue stream.

CHALLENGE

"High costs of implants and surgical technologies."

Around 32% of orthopedic hospitals reported rising costs for hip replacement implants in 2024, averaging a 14% increase in titanium and ceramic materials. Around 29% of hospitals cited robotic surgical systems as exceeding $1.5 million in acquisition costs. Around 27% of smaller clinics reported inability to afford advanced surgical systems. Around 22% of developing regions reported shortages of skilled surgeons for robotic-assisted hip replacement. Around 37% of hospitals globally faced reimbursement delays from insurers, impacting affordability. The Hip Replacement market Analysis identifies high cost and accessibility as the major operational challenge.

Hip Replacement Market Segmentation Analysis

The Hip Replacement market is segmented by type and application. In 2024, total hip replacement implants represented 46% of global demand, partial hip replacement 21%, hip resurfacing 12%, and revision implants 21%. By application, hospitals accounted for 63% of procedures, orthopedic clinics 27%, and ambulatory surgical centers 10%. The Hip Replacement market Analysis highlights that implant choice varies by patient age, activity level, and severity of joint degeneration, while application segments are influenced by healthcare infrastructure and surgical technology availability.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Total Hip Replacement Implant: Total hip replacement accounted for 46% of all hip implant procedures in 2024, equal to 736,000 surgeries globally. Around 64% of implants used cementless fixation, while 36% relied on cemented designs. Around 42% of total hip replacement implants used ceramic-on-polyethylene bearings, while 27% adopted ceramic-on-ceramic. Around 29% of procedures were robotic-assisted. The Hip Replacement market Insights identify total hip replacement as the most dominant segment, particularly among patients aged above 60 years, who accounted for 62% of total procedures globally.

The Total Hip Replacement Implant segment in the Hip Replacement market is projected at USD 4250.00 million in 2025 accounting for 46% global share and expected to grow at a CAGR of 3.8% through 2034.

Top 5 Major Dominant Countries in the Total Hip Replacement Implant Segment

• United States Market Size USD 1360.00 million in 2025 32% share CAGR 3.9% driven by over 450,000 procedures annually and strong adoption of cementless implants
• Germany Market Size USD 680.00 million in 2025 16% share CAGR 3.7% supported by 121,000 annual hip surgeries and extensive use of robotic-assisted platforms
• China Market Size USD 552.50 million in 2025 13% share CAGR 4.1% reflecting 143,000 annual procedures and rising government healthcare infrastructure investment
• India Market Size USD 382.50 million in 2025 9% share CAGR 4.2% fueled by 97,000 hip replacements annually with increasing adoption of cementless designs
• France Market Size USD 340.00 million in 2025 8% share CAGR 3.6% driven by 92,000 hip replacement procedures annually and strong adoption of ceramic implants

Partial Hip Replacement Implant: Partial hip replacement represented 21% of total hip implant procedures in 2024, equal to 336,000 surgeries. Around 58% of partial hip replacements were tied to elderly patients suffering hip fractures. Around 32% of partial implants used cementless fixation, while 68% used cemented. Around 41% of procedures were performed in Europe, where elderly populations accounted for 49% of total demand. Around 27% of partial hip replacements were performed in outpatient centers. The Hip Replacement market Share highlights partial hip replacement as a critical solution for trauma-related injuries.

The Partial Hip Replacement Implant segment is estimated at USD 1940.00 million in 2025 representing 21% of Hip Replacement market Size with a CAGR of 3.4% projected through 2034.

Top 5 Major Dominant Countries in the Partial Hip Replacement Implant Segment

• United States Market Size USD 620.80 million in 2025 32% share CAGR 3.5% tied to elderly trauma-related fractures and outpatient adoption
• Italy Market Size USD 310.40 million in 2025 16% share CAGR 3.3% supported by 76,000 partial hip replacements annually
• China Market Size USD 252.20 million in 2025 13% share CAGR 3.6% reflecting aging demographics and increasing fracture incidence
• Spain Market Size USD 174.60 million in 2025 9% share CAGR 3.2% linked to 72,000 hip surgeries with partial procedures prominent in elderly care
• Japan Market Size USD 155.20 million in 2025 8% share CAGR 3.3% representing high demand among elderly populations with over 69,000 hip procedures annually

Hip Resurfacing Implant: Hip resurfacing represented 12% of total hip replacement procedures in 2024, equal to 192,000 surgeries. Around 72% of resurfacing procedures were conducted in patients under 50 years. Around 67% of hip resurfacing implants used metal-on-metal bearings. Around 36% of global procedures were performed in the USA, equal to 69,000 cases. Around 28% of resurfacing procedures were tied to sports-related injuries. Around 23% of patients undergoing resurfacing required revisions within 15 years. The Hip Replacement market Analysis positions hip resurfacing as a growing option among younger, active patients seeking bone-preserving alternatives.

The Hip Resurfacing Implant segment is valued at USD 1110.00 million in 2025 representing 12% global share with CAGR of 3.5% supported by younger patient adoption and preference for bone-preserving solutions.

Top 5 Major Dominant Countries in the Hip Resurfacing Implant Segment

• United States Market Size USD 399.60 million in 2025 36% share CAGR 3.6% linked to 69,000 resurfacing cases annually among patients under 50 years
• United Kingdom Market Size USD 166.50 million in 2025 15% share CAGR 3.4% with strong uptake in younger sports-injury-related cases
• India Market Size USD 144.30 million in 2025 13% share CAGR 3.7% serving younger populations and sports-related cases among 55,000 annual hip procedures
• Australia Market Size USD 122.10 million in 2025 11% share CAGR 3.5% driven by 39,000 procedures annually with focus on resurfacing implants
• Germany Market Size USD 111.00 million in 2025 10% share CAGR 3.3% tied to younger patient adoption with 121,000 hip procedures annually

Revision Hip Replacement Implant: Revision hip replacement represented 21% of procedures in 2024, equal to 336,000 surgeries globally. Around 47% of revisions were due to implant wear and loosening, while 21% were caused by infections. Around 33% of revision procedures used cementless implants, while 67% used cemented. Around 42% of revision surgeries were performed in North America and Europe combined, reflecting higher rates of primary implant aging. Around 29% of revision implants integrated ceramic bearings. The Hip Replacement market Outlook identifies revision implants as a growing category due to an increasing pool of aging patients.

The Revision Hip Replacement Implant segment is projected at USD 1928.95 million in 2025 representing 21% global share with CAGR of 3.7% driven by implant wear failures and increasing aging populations requiring revisions.

Top 5 Major Dominant Countries in the Revision Hip Replacement Implant Segment

• United States Market Size USD 656.00 million in 2025 34% share CAGR 3.8% linked to aging implants and high volume of revision surgeries
• Germany Market Size USD 309.00 million in 2025 16% share CAGR 3.6% reflecting strong surgical capacity and large aging patient pool
• China Market Size USD 270.00 million in 2025 14% share CAGR 4.0% linked to 143,000 annual procedures and revision demand
• France Market Size USD 213.00 million in 2025 11% share CAGR 3.5% with revisions rising due to longer implant life cycles
• Japan Market Size USD 173.00 million in 2025 9% share CAGR 3.6% tied to elderly demographics and high healthcare infrastructure support

BY APPLICATION

Hospitals: Hospitals accounted for 63% of hip replacement procedures in 2024, equal to 1.0 million surgeries globally. Around 41% of hospital-based hip replacements were robotic-assisted. Around 67% of hospital implants were cementless. Around 34% of hospitals globally offered outpatient hip replacement services. Around 39% of hospital-based hip replacements were performed on patients above 70 years. The Hip Replacement market Forecast highlights hospitals as the dominant application segment due to advanced facilities.

The Hospitals segment in the Hip Replacement market is valued at USD 5814.00 million in 2025 63% share growing at a CAGR of 3.7% through 2034 reflecting dominance of advanced surgical infrastructure.

Top 5 Major Dominant Countries in the Hospitals Application

• United States Market Size USD 2034.90 million in 2025 35% share CAGR 3.8% hospitals conducting 62% of national hip replacements
• Germany Market Size USD 930.24 million in 2025 16% share CAGR 3.6% hospitals managing 78% of total orthopedic procedures
• China Market Size USD 813.96 million in 2025 14% share CAGR 3.9% hospitals conducting 70% of national hip replacement surgeries
• France Market Size USD 639.54 million in 2025 11% share CAGR 3.5% hospitals dominating elderly patient treatment
• India Market Size USD 465.12 million in 2025 8% share CAGR 4.1% driven by government-backed expansion of hospital orthopedic units

Orthopedic Clinics: Orthopedic clinics represented 27% of hip replacement procedures in 2024, equal to 432,000 surgeries globally. Around 52% of orthopedic clinic cases were performed in North America and Europe. Around 29% of clinics offered robotic-assisted implants. Around 46% of clinic-based hip replacements were tied to patients aged 60–70 years. Around 22% of clinic surgeries involved hip resurfacing for younger patients. The Hip Replacement market Research Report identifies orthopedic clinics as essential for decentralized patient care.

The Orthopedic Clinics segment is estimated at USD 2491.82 million in 2025 representing 27% share of Hip Replacement market Size growing at CAGR of 3.5% supported by community based orthopedic practices.

Top 5 Major Dominant Countries in the Orthopedics Clinics Application

• United States market size USD 847.20 million in 2025 34% share CAGR 3.6% orthopedic clinics managing 27% of national hip replacement demand.
• France market size USD 373.77 million in 2025 15% share CAGR 3.4% orthopedic clinics widely used for outpatient partial replacements.
• Germany market size USD 348.85 million in 2025 14% share CAGR 3.5% decentralized orthopedic care handling 25% of national procedures.
• India market size USD 298.00 million in 2025 12% share CAGR 3.8% orthopedic clinics expanding rapidly in metropolitan cities.
• China market size USD 273.20 million in 2025 11% share CAGR 3.6% private orthopedic clinics driving accessible surgical interventions.

Ambulatory Surgical Centers: Ambulatory surgical centers accounted for 10% of hip replacement procedures in 2024, equal to 160,000 surgeries globally. Around 62% of ASC cases used minimally invasive approaches. Around 38% of ASC surgeries were outpatient same-day procedures. Around 27% of ASC demand was driven by younger patients under 55 years. Around 41% of ASC surgeries were performed in the USA. Around 21% of ASC adoption globally was tied to insurance-driven cost reduction. The Hip Replacement market Opportunities highlight ASC growth as critical for efficiency and cost management.

The Ambulatory Surgical Centers segment is valued at USD 923.13 million in 2025 representing 10% of global share growing at CAGR of 3.3% with strong adoption of outpatient hip replacement surgeries.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centers Application

• United States market size USD 378.00 million in 2025 41% share CAGR 3.4% ambulatory centers managing more than 65,000 hip procedures annually.
• United Kingdom market size USD 138.00 million in 2025 15% share CAGR 3.2% driven by NHS initiatives promoting outpatient surgeries.
• Australia market size USD 120.00 million in 2025 13% share CAGR 3.3% outpatient centers handling 18% of national hip surgeries annually.
• Canada market size USD 102.00 million in 2025 11% share CAGR 3.2% outpatient surgeries growing due to cost effective treatment models.
• India market size USD 83.00 million in 2025 9% share CAGR 3.5% ambulatory centers rising in metropolitan cities with younger patient base.

Hip Replacement Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

The Hip Replacement market recorded over 1.6 million global hip replacement surgeries in 2024, with regional differences reflecting demographics, infrastructure, and technological integration. North America held 39% of the market with 624,000 procedures, Europe accounted for 27% with 432,000, Asia-Pacific contributed 25% with 400,000, and the Middle East & Africa represented 9% with 144,000. The Hip Replacement market Analysis highlights North America’s dominance due to high adoption of robotic-assisted procedures, while Asia-Pacific is showing strong momentum due to aging populations and trauma-related demand.

North America

North America accounted for 39% of the Hip Replacement market Size in 2024, representing 624,000 procedures. The United States led with 450,000 surgeries, followed by Canada at 102,000 and Mexico at 72,000. Around 47% of procedures in the region used robotic-assisted technologies, equal to 293,000 cases. Outpatient hip replacement surgeries accounted for 38%, or 237,000 cases, supported by insurance coverage and improved minimally invasive techniques. Cementless implants dominated at 54% share, while cemented designs represented 46%. Around 29% of patients were under 60 years, reflecting growing acceptance of hip resurfacing and partial implants. Hospitals performed 62% of procedures, while orthopedic clinics managed 28%.

The North America Hip Replacement market Size is USD 3600.00 million in 2025 representing 39% of global share with CAGR of 3.7% driven by aging populations high insurance coverage and adoption of robotic assisted surgeries.

North America - Major Dominant Countries in the Hip Replacement market

• United States market size USD 2700.00 million 75% share CAGR 3.8% with 450,000 annual procedures and strong outpatient growth trends.
• Canada market size USD 540.00 million 15% share CAGR 3.5% supported by 102,000 annual hip replacements across hospitals and clinics.
• Mexico market size USD 270.00 million 7.5% share CAGR 3.4% driven by rising orthopedic procedure adoption in urban hospitals.
• Cuba market size USD 54.00 million 1.5% share CAGR 3.2% supported by gradual expansion of orthopedic surgical infrastructure.
• Dominican Republic market size USD 36.00 million 1% share CAGR 3.3% small but growing orthopedic demand supported by private healthcare.

Europe

Europe represented 27% of the Hip Replacement market Share in 2024, equal to 432,000 hip replacement procedures. Germany led with 121,000 surgeries, France with 92,000, Italy with 76,000, Spain with 72,000, and the United Kingdom with 71,000. Around 49% of European hip replacement implants used ceramic bearings, reflecting stricter regulatory standards for implant safety. Around 29% of procedures were tied to elderly patients over 70 years, equivalent to 125,000 cases.

The Europe Hip Replacement market Size is USD 2491.82 million in 2025 representing 27% of global share with CAGR of 3.5% supported by elderly populations ceramic implant adoption and high procedure volume across leading healthcare systems.

Europe - Major Dominant Countries in the Hip Replacement market

• Germany market size USD 680.00 million 27% share CAGR 3.6% supported by more than 121,000 hip replacement surgeries annually with robotic assisted platforms expanding steadily.
• France market size USD 575.00 million 23% share CAGR 3.4% supported by more than 94,000 procedures annually with strong adoption of ceramic implant materials.
• United Kingdom market size USD 500.00 million 20% share CAGR 3.5% supported by 71,000 annual hip replacement surgeries across NHS and private facilities.
• Italy market size USD 435.00 million 17% share CAGR 3.3% supported by 76,000 hip replacement surgeries annually with emphasis on minimally invasive procedures.
• Spain market size USD 301.82 million 13% share CAGR 3.3% supported by 65,000 annual procedures with elderly populations driving majority of demand.

Asia-Pacific

Asia-Pacific accounted for 25% of the Hip Replacement market Size in 2024, with 400,000 procedures. China led with 143,000 surgeries, India followed with 97,000, Japan had 69,000, South Korea 52,000, and Australia 39,000. Around 44% of regional hip replacements were linked to osteoarthritis, equal to 176,000 cases. Around 27% of implants used ceramic-on-polyethylene combinations, reflecting affordability and durability. Around 18% of surgeries were conducted in ambulatory centers, equal to 72,000 procedures, reflecting rising outpatient adoption.

The Asia Hip Replacement market Size is USD 2307.24 million in 2025 representing 25% of global share with CAGR of 3.9% driven by expanding healthcare infrastructure large elderly populations and rising demand for orthopedic implants in emerging economies.

Asia - Major Dominant Countries in the Hip Replacement market

• China market size USD 828.00 million 36% share CAGR 4.0% supported by 143,000 hip replacement surgeries annually with rapidly expanding implant production facilities.
• India market size USD 575.00 million 25% share CAGR 4.1% supported by 97,000 hip replacement procedures annually with urban hospitals leading in adoption.
• Japan market size USD 414.00 million 18% share CAGR 3.7% supported by more than 69,000 hip procedures annually with elderly patients forming the largest segment.
• South Korea market size USD 276.00 million 12% share CAGR 3.8% supported by 52,000 annual hip replacements and rising interest in robotic surgeries.
• Australia market size USD 207.00 million 9% share CAGR 3.5% supported by 39,000 annual procedures with resurfacing implants commonly used among younger patients.

Middle East & Africa

The Middle East & Africa accounted for 9% of the Hip Replacement market Share in 2024, performing 144,000 procedures. Saudi Arabia led with 41,000 cases, South Africa with 33,000, UAE with 29,000, Egypt with 25,000, and Nigeria with 16,000. Around 38% of procedures were trauma-related fractures, equal to 55,000 surgeries, highlighting higher accident rates. Around 24% of hospitals integrated robotic-assisted hip replacement systems, representing 34,000 cases, particularly in the UAE and Saudi Arabia. Around 21% of patients were under 55 years, indicating higher demand from younger populations.

The Middle East and Africa Hip Replacement market Size is USD 830.89 million in 2025 representing 9% of global share with CAGR of 3.4% supported by growing healthcare expenditure expansion of private hospitals and rising adoption of orthopedic implants.

Middle East and Africa - Major Dominant Countries in the Hip Replacement market

• Saudi Arabia market size USD 248.00 million 30% share CAGR 3.5% supported by 41,000 annual hip replacement procedures driven by strong healthcare infrastructure investments.
• South Africa market size USD 207.00 million 25% share CAGR 3.4% supported by 33,000 hip procedures annually with demand concentrated in urban hospitals.
• UAE market size USD 166.00 million 20% share CAGR 3.4% supported by 29,000 procedures annually with robotic assisted technologies gaining rapid adoption.
• Egypt market size USD 124.00 million 15% share CAGR 3.3% supported by more than 25,000 procedures annually with increasing government focus on orthopedic care.
• Nigeria market size USD 83.00 million 10% share CAGR 3.3% supported by 16,000 hip replacement surgeries annually despite limited access in rural regions.

List of Top Hip Replacement Market Companies

• Stryker
• Zimmer Biomet
• MicroPort Scientific
• Exactech
• Smith & Nephew
• OMNIlife science
• B. Braun
• DJO Global
• Johnson & Johnson

Top Two Companies With Highest Share

• Stryker – Controlled 14% of global hip implant share in 2024, equal to over 224,000 implant sales worldwide.
• Zimmer Biomet – Accounted for 12% of global market share in 2024, equal to around 192,000 implant units distributed globally.

Investment Analysis and Opportunities

In 2024, over 580 investment projects were initiated in the Hip Replacement market globally. Around 39% of investments targeted robotic-assisted surgical platforms, representing 226 projects. Around 28% of investments were directed at biomaterial development, including titanium and ceramic composites. Around 22% of projects focused on outpatient and ambulatory surgical centers, adding 92 new facilities worldwide. North America accounted for 41% of global investments, while Asia-Pacific contributed 27%. Around 19% of investments targeted implant longevity R&D, aiming to reduce revision surgeries. Around 21% of funding was allocated to digital imaging technologies for preoperative planning. The Hip Replacement market Opportunities emphasize technological advancement and outpatient expansion as key investment areas.

New Product Development

Between 2023 and 2025, around 610 new hip replacement products were launched globally. Around 34% were advanced titanium implants, 28% were ceramic-based solutions, 21% were hybrid resurfacing implants, and 17% were revision implants. Around 43% of launches supported robotic-assisted compatibility. Around 32% of new implants were designed for outpatient use, with streamlined surgical instruments reducing procedure times by 27%. Around 26% of new products included AI-driven imaging integration. Around 18% of innovations targeted patients under 55 years, offering long-lasting implant materials. Around 21% of new launches originated in Europe, 33% in North America, and 38% in Asia-Pacific. Around 22% of implants launched in 2024 were fully bio-compatible. The Hip Replacement market Forecast highlights product innovation as central to market competitiveness.

Five Recent Developments 

• Stryker expanded production capacity by 19%, adding 150,000 new units of hip implants annually.
• Zimmer Biomet launched robotic-compatible hip resurfacing implants, increasing adoption in 72 hospitals globally.
• Smith & Nephew introduced titanium-based revision implants with 27% longer average durability.
• Johnson & Johnson invested in 14 new outpatient surgical centers supporting minimally invasive hip replacement procedures.
• MicroPort Scientific launched ceramic-on-ceramic implants with 32% higher wear resistance.

Report Coverage of Hip Replacement market

The Hip Replacement market Research Report covers global dynamics, segmentation, and adoption patterns across hospitals, clinics, and ambulatory centers. In 2024, total hip replacements represented 46% of global demand, partial 21%, resurfacing 12%, and revision 21%. Hospitals accounted for 63% of procedures, clinics 27%, and ambulatory centers 10%. North America led with 39% of global share, Europe followed with 27%, Asia-Pacific with 25%, and MEA with 9%. Around 580 investments and 610 product launches were recorded globally between 2023 and 2025. The Hip Replacement market Analysis emphasizes technological advancements, outpatient expansion, and implant innovations as the leading drivers shaping market growth.

Hip Replacement Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2929.14 Million in 2026
Market Size Value By	USD 13195.52 Million by 2035
Growth Rate	CAGR of 3.64% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Total Hip Replacement Implant Partial Hip Replacement Implant Hip Resurfacing Implant Revision Hip Replacement Implant By Application : Hospitals Orthopedics Clinics Ambulatory Surgical Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample